⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RNA News
Avidity Biosciences, Inc. Common Stock
Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
prnewswire.com
RNA
Form 8-K
sec.gov
RNA
Atrium Therapeutics Announces FDA Clearance of Investigational New Drug Application for ATR 1072 for Treatment of PRKAG2 Syndrome
prnewswire.com
RNA
Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
prnewswire.com
RNA
Form 8-K
sec.gov
RNA
Atrium Therapeutics Reports First Quarter 2026 Financial Results
prnewswire.com
RNA
Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration
prnewswire.com
BMY
RNA
Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
prnewswire.com
RNA
Atrium Therapeutics Launches with Approximately $270 Million to Advance Novel RNA Medicines for Rare Genetic Cardiomyopathies
prnewswire.com
RNA
Form 8-K
sec.gov
RNAM
RNA